Dubai, UAE
NZ$ 8,484,645 - NZ$ 16,969,290
Data Analytics and Business Intelligence Expert, Artificial General Intelligence and Crypto asset Anti-Money laundering. Decentralised finance. ACAMS Certified.
Blockchain, Crypto Assets, DeFi, Anti-Money Laundering, AI
Oncology therapeutics redefined Onconetix, Inc. (Nasdaq: ONCO) (formerly Blue Water Biotech, Inc. (BWV)) is a commercial stage biotechnology company focused on the research, development and commercialization of proprietary therapeutics, diagnostics and services for clinicians and patients for oncology. The Company currently has Entadfi®, an FDA approved, oral therapeutic for the treatment of benign prostatic hyperplasia (BPH), a disorder of the prostate, and Proclarix®, an advanced proprietary diagnostic system for screening and diagnosis for men with indeterminate Prostate Specific Antigen (PSA) assessments in prostate cancer oncology. For more information, visit www.onconetix.com.
Innovating Healthcare and Life Sciences from Every Angle Throughout healthcare, providers, payers, and biopharma professionals are working hard to improve the system and deliver the best outcomes for patients and consumers. True change agents know it can’t be done alone. We strive to partner with you to reinforce your progress with our breakthrough technology and healthcare know-how. Together we’ll create an unshakeable system where you are empowered to do the work needed to transform healthcare.
Finance
Software
Technology
Agriculture
Business Services
Education & Training
Energy & Natural Resources
Entertainment & Leisure
Fashion & Beauty
Food & Beverage
Hospitality, Restaurants & Bars
Manufacturing & Engineering
Media
Medical & Sciences
Personal Services
Products & Inventions
Property
Retail
Sales & Marketing
Transportation
AIN helps investors and entrepreneurs build lasting and profitable relationships to build better businesses and brighter futures.